Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study

AICOPP group

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: As glomerular filtration rate (GFR) decreases, serum phosphate level increases. Previous reports indicated that serum phosphate level was associated with mortality in patients on dialysis. However, few reports have examined the association using dialysis initiation as the baseline period. METHODS: This was a multicenter prospective cohort analysis including 1492 patients. Patients were classified into four quartiles based on the serum phosphate level at dialysis initiation, with Q1 being the lowest and Q4 the highest. All-cause mortality after dialysis initiation was compared using the log-rank test. The propensity score represented the probability of being assigned to group Q1 or Q2-4. All-cause mortality was compared in propensity score-matched patients by using the log-rank test for Kaplan-Meier curves. All-cause mortality of Q1 was compared with that for Q2-4 using multivariate Cox proportional hazard regression analysis. All-cause mortality was also determined among stratified groups with or without use of phosphate binders. RESULTS: Significant differences in cumulative survival rates were observed between the four groups (p < .001). After propensity score-matching, mortality was significantly higher in the Q1 group than the Q2-4 group (p = .046). All-cause mortality was significantly higher in the Q1 group after adjustment for history of CAD (hazard ratio [HR] = 0.76, 95% confidence interval [CI]: 0.58 - 1.00, p = .048). However, there was no significant difference between the two groups after adjustment for estimated GFR. CONCLUSION: The serum phosphate level at the time of dialysis initiation was associated with all-cause mortality. However, the serum phosphate level was dependent on the renal function.

Original languageEnglish
Pages (from-to)475-482
Number of pages8
JournalRenal failure
Volume40
Issue number1
DOIs
Publication statusPublished - 01-11-2018

Fingerprint

Dialysis
Cohort Studies
Phosphates
Prospective Studies
Mortality
Serum
Propensity Score
Glomerular Filtration Rate
Kaplan-Meier Estimate
Survival Rate
Regression Analysis
Confidence Intervals
Kidney

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine
  • Nephrology

Cite this

@article{75fd79a793bd4890be81f75eb32c54d4,
title = "Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study",
abstract = "INTRODUCTION: As glomerular filtration rate (GFR) decreases, serum phosphate level increases. Previous reports indicated that serum phosphate level was associated with mortality in patients on dialysis. However, few reports have examined the association using dialysis initiation as the baseline period. METHODS: This was a multicenter prospective cohort analysis including 1492 patients. Patients were classified into four quartiles based on the serum phosphate level at dialysis initiation, with Q1 being the lowest and Q4 the highest. All-cause mortality after dialysis initiation was compared using the log-rank test. The propensity score represented the probability of being assigned to group Q1 or Q2-4. All-cause mortality was compared in propensity score-matched patients by using the log-rank test for Kaplan-Meier curves. All-cause mortality of Q1 was compared with that for Q2-4 using multivariate Cox proportional hazard regression analysis. All-cause mortality was also determined among stratified groups with or without use of phosphate binders. RESULTS: Significant differences in cumulative survival rates were observed between the four groups (p < .001). After propensity score-matching, mortality was significantly higher in the Q1 group than the Q2-4 group (p = .046). All-cause mortality was significantly higher in the Q1 group after adjustment for history of CAD (hazard ratio [HR] = 0.76, 95{\%} confidence interval [CI]: 0.58 - 1.00, p = .048). However, there was no significant difference between the two groups after adjustment for estimated GFR. CONCLUSION: The serum phosphate level at the time of dialysis initiation was associated with all-cause mortality. However, the serum phosphate level was dependent on the renal function.",
author = "{AICOPP group} and Akiko Owaki and Daijo Inaguma and Isao Aoyama and Shinichiro Inaba and Daijo Inaguma and Eri Ito and Kazuo Takahashi and Hiroki Hayashi and Midori Hasegawa and Yukio Yuzawa",
year = "2018",
month = "11",
day = "1",
doi = "10.1080/0886022X.2018.1499530",
language = "English",
volume = "40",
pages = "475--482",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "1",

}

Serum phosphate level at initiation of dialysis is associated with all-cause mortality : a multicenter prospective cohort study. / AICOPP group.

In: Renal failure, Vol. 40, No. 1, 01.11.2018, p. 475-482.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum phosphate level at initiation of dialysis is associated with all-cause mortality

T2 - a multicenter prospective cohort study

AU - AICOPP group

AU - Owaki, Akiko

AU - Inaguma, Daijo

AU - Aoyama, Isao

AU - Inaba, Shinichiro

AU - Inaguma, Daijo

AU - Ito, Eri

AU - Takahashi, Kazuo

AU - Hayashi, Hiroki

AU - Hasegawa, Midori

AU - Yuzawa, Yukio

PY - 2018/11/1

Y1 - 2018/11/1

N2 - INTRODUCTION: As glomerular filtration rate (GFR) decreases, serum phosphate level increases. Previous reports indicated that serum phosphate level was associated with mortality in patients on dialysis. However, few reports have examined the association using dialysis initiation as the baseline period. METHODS: This was a multicenter prospective cohort analysis including 1492 patients. Patients were classified into four quartiles based on the serum phosphate level at dialysis initiation, with Q1 being the lowest and Q4 the highest. All-cause mortality after dialysis initiation was compared using the log-rank test. The propensity score represented the probability of being assigned to group Q1 or Q2-4. All-cause mortality was compared in propensity score-matched patients by using the log-rank test for Kaplan-Meier curves. All-cause mortality of Q1 was compared with that for Q2-4 using multivariate Cox proportional hazard regression analysis. All-cause mortality was also determined among stratified groups with or without use of phosphate binders. RESULTS: Significant differences in cumulative survival rates were observed between the four groups (p < .001). After propensity score-matching, mortality was significantly higher in the Q1 group than the Q2-4 group (p = .046). All-cause mortality was significantly higher in the Q1 group after adjustment for history of CAD (hazard ratio [HR] = 0.76, 95% confidence interval [CI]: 0.58 - 1.00, p = .048). However, there was no significant difference between the two groups after adjustment for estimated GFR. CONCLUSION: The serum phosphate level at the time of dialysis initiation was associated with all-cause mortality. However, the serum phosphate level was dependent on the renal function.

AB - INTRODUCTION: As glomerular filtration rate (GFR) decreases, serum phosphate level increases. Previous reports indicated that serum phosphate level was associated with mortality in patients on dialysis. However, few reports have examined the association using dialysis initiation as the baseline period. METHODS: This was a multicenter prospective cohort analysis including 1492 patients. Patients were classified into four quartiles based on the serum phosphate level at dialysis initiation, with Q1 being the lowest and Q4 the highest. All-cause mortality after dialysis initiation was compared using the log-rank test. The propensity score represented the probability of being assigned to group Q1 or Q2-4. All-cause mortality was compared in propensity score-matched patients by using the log-rank test for Kaplan-Meier curves. All-cause mortality of Q1 was compared with that for Q2-4 using multivariate Cox proportional hazard regression analysis. All-cause mortality was also determined among stratified groups with or without use of phosphate binders. RESULTS: Significant differences in cumulative survival rates were observed between the four groups (p < .001). After propensity score-matching, mortality was significantly higher in the Q1 group than the Q2-4 group (p = .046). All-cause mortality was significantly higher in the Q1 group after adjustment for history of CAD (hazard ratio [HR] = 0.76, 95% confidence interval [CI]: 0.58 - 1.00, p = .048). However, there was no significant difference between the two groups after adjustment for estimated GFR. CONCLUSION: The serum phosphate level at the time of dialysis initiation was associated with all-cause mortality. However, the serum phosphate level was dependent on the renal function.

UR - http://www.scopus.com/inward/record.url?scp=85059794896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059794896&partnerID=8YFLogxK

U2 - 10.1080/0886022X.2018.1499530

DO - 10.1080/0886022X.2018.1499530

M3 - Article

C2 - 30153079

AN - SCOPUS:85059794896

VL - 40

SP - 475

EP - 482

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 1

ER -